Notice to the media - The Honourable Ginette Petitpas Taylor, federal Minister of Health, will be in Montréal all day Monday, December 11th
MONTREAL, Dec. 8, 2017 /CNW/ - The Honourable Ginette Petitpas Taylor, federal Minister of Health, will be in Montréal all day Monday December 11th.
In Montréal, she will meet, among others, the Mayor of Montréal, Valérie Plante. She will also participate in a roundtable with parents and youth on cannabis prevention at Maison Jean Lapointe, will be visiting the CHU Sainte-Justine, and will make an announcement on research related to opioids at the University of Montreal Hospital Research Centre (CRCHUM).
Media are invited to a press event at the CRCHUM.
Date December 11, 2017
Time 3:15 PM
Location Agora, 5th Floor, Pavillion R University of Montréal Hospital Research Centre (CRCHUM) 900, Saint-Denis Street Montréal, Québec
Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today...
Stevanato Group S.p.A. , a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will issue financial results for the first...
Bruker Corporation today announced it will report first quarter 2024 financial results before market opening on Thursday, May 2, 2024. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and current...
Gilead Sciences, Inc. announced today its first quarter 2024 results of operations.
"Gilead delivered another strong quarter of revenue growth in the first quarter with 6% year-over-year growth in our base business driven by HIV, Oncology and...
DexCom, Inc. today reported its financial results as of and for the quarter ended March 31, 2024.
First Quarter 2024 Financial Highlights:
Revenue grew 24% year-over-year to $921.0 million on a reported basis and 25% year-over-year on an...
Ironwood Pharmaceuticals, Inc. today announced it will host its first quarter 2024 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, May 9, 2024. Individuals interested in participating in the call should dial (888)...
